These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 849855)

  • 1. [Hemolytic components of anemia in patients with long-term hemodialysis].
    Heilmann E
    Fortschr Med; 1977 Feb; 95(7):430-2. PubMed ID: 849855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The nature of the humoral hemolytic factors in patients with chronic kidney failure].
    Ershova LI; Gorbunova NA
    Ter Arkh; 1997; 69(7):46-50. PubMed ID: 9424758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study of anemia in 86 patients on hemodialysis (author's transl)].
    Serra A; Camps J; Morlans M; Olmos A; Carrera A; Soriano B; Rodríguez JA; Pelegrí A; Bartolomé J; Piera L
    Med Clin (Barc); 1981 May; 76(10):439-43. PubMed ID: 7242164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proceedings: Plasma hemoglobin in patients with intermittent hemodialysis with special reference to various dialysis procedures].
    Heilmann E; Tillmann P; Lunke G
    Schweiz Med Wochenschr; 1975 Dec; 105(51):1766-7. PubMed ID: 1215971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis.
    Zehnder C; Blumberg A
    Clin Nephrol; 1989 Feb; 31(2):55-9. PubMed ID: 2920469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lipid peroxidation as a possible mechanism of erythrocyte damage in patients with chronic kidney failure on hemodialysis].
    Balashova TS; Rud'ko IA; Ermolenko VM; Tsalenchuk IaP; Kubatiev AA
    Ter Arkh; 1992; 64(6):66-9. PubMed ID: 1440343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients.
    Gallucci MT; Lubrano R; Meloni C; Morosetti M; Manca di Villahermosa S; Scoppi P; Palombo G; Castello MA; Casciani CU
    Clin Nephrol; 1999 Oct; 52(4):239-45. PubMed ID: 10543326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Human recombinant erythropoietin in the treatment of anemia in patients on long-term hemodialysis].
    Boratyńska M; Szewczyk Z; Szepietowski T; Czyz W; Cybulski K; Bogucki J; Szczepański J
    Przegl Lek; 1990; 47(11):741-5. PubMed ID: 2098840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Etiopathogenic mechanisms of anemia in hemodialysis patients].
    Marco Franco JE; Alarcón Zurita A; Dalmau Diana M; Pizá Buñola C; Morey Molina A; Bestard Palmer J; Mairata Bosch S; Ribas Mundó M
    Rev Clin Esp; 1983 Jan; 168(2):83-5. PubMed ID: 6344155
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemoglobin variability in dialysis patients.
    Brimble KS; Clase CM
    J Am Soc Nephrol; 2007 Aug; 18(8):2218-20. PubMed ID: 17627931
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of hemolysis in regular hemodialysis patients by measuring carbon monoxide production rate.
    Lerner R; Werner B; Asaba H; Ternstedt B; Elmqvist E
    Clin Nephrol; 1983 Nov; 20(5):239-43. PubMed ID: 6652977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum erythropoietin (ESF) titers in anemia of chronic renal failure.
    de Klerk G; Wilmink JM; Rosengarten PC; Vet RJ; Goudsmit R
    J Lab Clin Med; 1982 Nov; 100(5):720-34. PubMed ID: 7130829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Familial hemolytic anemia and terminal renal failure (author's transl)].
    Heilmann E; Wessels G; Loew H
    Med Klin; 1976 Jan; 71(3):110-1. PubMed ID: 1250189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous erythropoietin in the treatment of renal anaemia.
    Drinovec J; Varl J
    Przegl Lek; 1992; 49(1-2):38-40. PubMed ID: 1455004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal anemia].
    Uhl N
    Med Klin; 1976 Mar; 71(13):531-5. PubMed ID: 772393
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of erythropoietin in patients with chronic renal insufficiency and in hemodialysis].
    Cuero CJ; Pérez Guardia E; de Rivera C
    Rev Med Panama; 1996; 21(1-2):55-9. PubMed ID: 8966240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum immunoreactive erythropoietin in patients with end stage renal disease.
    Gimenez LF; Watson AJ; Spivak JL
    Prog Clin Biol Res; 1990; 352():493-504. PubMed ID: 2402519
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anemia in patients with chronic kidney failure undergoing systematic hemodialysis treatment].
    Landar' VA; Sarycheva TG; Shemetov VD; Kozinets GI
    Urol Nefrol (Mosk); 1989; (1):54-5. PubMed ID: 2718284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol adherence and the ability to achieve target haemoglobin levels in haemodialysis patients.
    Chan K; Moran J; Hlatky M; Lafayette R
    Nephrol Dial Transplant; 2009 Jun; 24(6):1956-62. PubMed ID: 19176685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anemia in chronic renal insufficiency].
    Feiman R; Mena Castro E; Gordillo Paniagua G
    Bol Med Hosp Infant Mex; 1981; 38(2):231-41. PubMed ID: 7259844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.